{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:05:20Z","timestamp":1790960720438,"version":"4.1.0"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA007290"],"award-info":[{"award-number":["AA007290"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA12722313"],"award-info":[{"award-number":["AA12722313"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000027","name":"National Institute on Alcohol Abuse and Alcoholism","doi-asserted-by":"publisher","award":["AA027858"],"award-info":[{"award-number":["AA027858"]}],"id":[{"id":"10.13039\/100000027","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-92313-0","type":"journal-article","created":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T19:56:46Z","timestamp":1743019006000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Baseline gut microbiome and metabolites are correlated with changes in alcohol consumption in participants in a randomized Zonisamide clinical trial"],"prefix":"10.1038","volume":"15","author":[{"given":"Liv R.","family":"Dedon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanshu","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhua","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiwei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert J.","family":"Arias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Covault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjiao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"key":"92313_CR1","unstructured":"WHO. Global status report on alcohol and health 2018. World Health Organisation. 478 (2018)."},{"key":"92313_CR2","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S0140-6736(19)31775-1","volume":"394","author":"AF Carvalho","year":"2019","unstructured":"Carvalho, A. F., Heilig, M., Perez, A., Probst, C. & Rehm, J. Alcohol use disorders. Lancet 394, 781\u2013792 (2019).","journal-title":"Lancet"},{"key":"92313_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12889-017-4587-y","volume":"18","author":"M Schwarzinger","year":"2018","unstructured":"Schwarzinger, M., Thi\u00e9baut, S. P., Baillot, S., Mallet, V. & Rehm, J. Alcohol use disorders and associated chronic disease \u2013 a National retrospective cohort study from France. BMC Public Health\u00a018, 43 (2018).","journal-title":"BMC Public Health"},{"key":"92313_CR4","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/add.13757","volume":"112","author":"J Rehm","year":"2017","unstructured":"Rehm, J. et al. The relationship between different dimensions of alcohol use and the burden of disease\u2014an update. Addiction 112, 968\u20131001 (2017).","journal-title":"Addiction"},{"key":"92313_CR5","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.drugalcdep.2018.08.013","volume":"192","author":"LT Wu","year":"2018","unstructured":"Wu, L. T., Zhu, H. & Ghitza, U. E. Multicomorbidity of chronic diseases and substance use disorders and their association with hospitalization: results from electronic health records data. Drug Alcohol Depend. 192, 316\u2013323 (2018).","journal-title":"Drug Alcohol Depend."},{"key":"92313_CR6","first-page":"155","volume":"35","author":"KD Shield","year":"2013","unstructured":"Shield, K. D., Parry, C. & Rehm, J. Chronic diseases and conditions related to alcohol use. Alcohol Res. 35, 155\u2013173 (2013).","journal-title":"Alcohol Res."},{"key":"92313_CR7","doi-asserted-by":"publisher","first-page":"E4485","DOI":"10.1073\/pnas.1415174111","volume":"111","author":"S Leclercq","year":"2014","unstructured":"Leclercq, S. et al. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc. Natl. Acad. Sci. 111, E4485\u2013E4493 (2014).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"92313_CR8","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3389\/fcimb.2022.840164","volume":"12","author":"AW Day","year":"2022","unstructured":"Day, A. W. & Kumamoto, C. A. Gut Microbiome dysbiosis in alcoholism: consequences for health and recovery. Front. Cell. Infect. Microbiol. 12, 198 (2022).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"92313_CR9","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.3390\/ijms24032461","volume":"24","author":"K Litwinowicz","year":"2023","unstructured":"Litwinowicz, K. & Gamian, A. Microbiome alterations in alcohol use disorder and alcoholic liver disease. Int. J. Mol. Sci. 24, 2461 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"92313_CR10","first-page":"223","volume":"37","author":"PA Engen","year":"2015","unstructured":"Engen, P. A., Green, S. J., Voigt, R. M., Forsyth, C. B. & Keshavarzian, A. The Gastrointestinal microbiome: alcohol effects on the composition of intestinal microbiota. Alcohol Res. 37, 223 (2015).","journal-title":"Alcohol Res."},{"key":"92313_CR11","doi-asserted-by":"publisher","first-page":"G966","DOI":"10.1152\/ajpgi.00380.2011","volume":"302","author":"EA Mutlu","year":"2012","unstructured":"Mutlu, E. A. et al. Colonic Microbiome is altered in alcoholism. Am. J. Physiology-Gastrointestinal Liver Physiol. 302, G966\u2013G978 (2012).","journal-title":"Am. J. Physiology-Gastrointestinal Liver Physiol."},{"key":"92313_CR12","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1080\/19490976.2019.1580097","volume":"10","author":"ST Bj\u00f8rkhaug","year":"2019","unstructured":"Bj\u00f8rkhaug, S. T. et al. Characterization of gut microbiota composition and functions in patients with chronic alcohol overconsumption. Gut Microbes\u00a010, 663\u2013675 (2019).","journal-title":"Gut Microbes"},{"key":"92313_CR13","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1080\/1028415X.2018.1493808","volume":"23","author":"AM Taylor","year":"2020","unstructured":"Taylor, A. M. & Holscher, H. D. A review of dietary and microbial connections to depression, anxiety, and stress. Nutr. Neurosci. 23, 237\u2013250 (2020).","journal-title":"Nutr. Neurosci."},{"key":"92313_CR14","doi-asserted-by":"crossref","unstructured":"Meckel, K. R. et al. Microbial short-chain fatty acids regulate drug seeking and transcriptional control in a model of cocaine seeking. Neuropsychopharmacology 49, 386\u2013394 (2023).","DOI":"10.1038\/s41386-023-01661-w"},{"key":"92313_CR15","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.3390\/ijms24032737","volume":"24","author":"M Davidson","year":"2023","unstructured":"Davidson, M. et al. Tryptophan and substance abuse: mechanisms and impact. Int. J. Mol. Sci. 2023. 24, 2737 (2023).","journal-title":"Int. J. Mol. Sci. 2023"},{"key":"92313_CR16","doi-asserted-by":"publisher","first-page":"109958","DOI":"10.1016\/j.pnpbp.2020.109958","volume":"102","author":"R Vidal","year":"2020","unstructured":"Vidal, R. et al. Plasma Tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity. Prog Neuropsychopharmacol. Biol. Psychiatry. 102, 109958 (2020).","journal-title":"Prog Neuropsychopharmacol. Biol. Psychiatry"},{"key":"92313_CR17","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1111\/liv.14383","volume":"40","author":"G Addolorato","year":"2020","unstructured":"Addolorato, G. et al. Gut microbiota compositional and functional fingerprint in patients with alcohol use disorder and alcohol-associated liver disease. Liver Int. 40, 878\u2013888 (2020).","journal-title":"Liver Int."},{"key":"92313_CR18","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/aps.2014.50","volume":"35","author":"J Liang","year":"2014","unstructured":"Liang, J. & Olsen, R. W. Alcohol use disorders and current Pharmacological therapies: the role of GABAA receptors. Acta Pharmacol. Sinica 2014. 35, 981\u2013993 (2014).","journal-title":"Acta Pharmacol. Sinica 2014"},{"key":"92313_CR19","doi-asserted-by":"publisher","first-page":"1218737","DOI":"10.3389\/fncir.2023.1218737","volume":"17","author":"RN Dharavath","year":"2023","unstructured":"Dharavath, R. N. et al. GABAergic signaling in alcohol use disorder and withdrawal: pathological involvement and therapeutic potential. Front. Neural Circuits\u00a017, 1218737 (2023).","journal-title":"Front. Neural Circuits"},{"key":"92313_CR20","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.addbeh.2004.12.011","volume":"30","author":"G Addolorato","year":"2005","unstructured":"Addolorato, G., Leggio, L., Abenavoli, L. & Gasbarrini, G. Neurobiochemical and clinical aspects of craving in alcohol addiction: A review. Addict. Behav. 30, 1209\u20131224 (2005).","journal-title":"Addict. Behav."},{"key":"92313_CR21","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41398-021-01610-5","volume":"11","author":"S Leclercq","year":"2021","unstructured":"Leclercq, S., Schwarz, M., Delzenne, N. M., St\u00e4rkel, P. & de Timary, P. Alterations of kynurenine pathway in alcohol use disorder and abstinence: a link with gut microbiota, peripheral inflammation and psychological symptoms. Transl Psychiatry\u00a011, 503 (2021).","journal-title":"Transl Psychiatry"},{"key":"92313_CR22","doi-asserted-by":"publisher","first-page":"110821","DOI":"10.1016\/j.drugalcdep.2023.110821","volume":"249","author":"Z Wang","year":"2023","unstructured":"Wang, Z., Huang, S., Li, L., Wen, Y. & Shang, D. Kynurenine metabolite changes in individuals with alcohol use disorder: A systematic review and meta-analysis. Drug Alcohol Depend. 249, 110821 (2023).","journal-title":"Drug Alcohol Depend."},{"key":"92313_CR23","doi-asserted-by":"publisher","first-page":"15688","DOI":"10.3390\/ijms232415688","volume":"23","author":"L Gao","year":"2022","unstructured":"Gao, L., Davies, D. L. & Asatryan, L. Sodium butyrate supplementation modulates neuroinflammatory response aggravated by antibiotic treatment in a mouse model of Binge-like ethanol drinking. Int. J. Mol. Sci. 23, 15688 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"92313_CR24","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40168-024-01829-6","volume":"12","author":"SC Bokoliya","year":"2024","unstructured":"Bokoliya, S. C. et al. Short-chain fatty acid valerate reduces voluntary alcohol intake in male mice. Microbiome 12, 108 (2024).","journal-title":"Microbiome"},{"key":"92313_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.alcohol.2021.12.003","volume":"100","author":"RE Reyes","year":"2022","unstructured":"Reyes, R. E., Gao, L., Zhang, Z., Davies, D. L. & Asatryan, L. Supplementation with sodium butyrate protects against antibiotic-induced increases in ethanol consumption behavior in mice. Alcohol 100, 1\u20139 (2022).","journal-title":"Alcohol"},{"key":"92313_CR26","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1111\/acer.14648","volume":"45","author":"JJ Mariani","year":"2021","unstructured":"Mariani, J. J. et al. Pilot randomized placebo-controlled clinical trial of high-dose Gabapentin for alcohol use disorder. Alcohol Clin. Exp. Res. 45, 1639\u20131652 (2021).","journal-title":"Alcohol Clin. Exp. Res."},{"key":"92313_CR27","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1176\/appi.ajp.2021.20121757","volume":"178","author":"JJ Prisciandaro","year":"2021","unstructured":"Prisciandaro, J. J. et al. Effects of Gabapentin on dorsal anterior cingulate cortex GABA and glutamate levels and their associations with abstinence in alcohol use disorder: A randomized clinical trial. Am. J. Psychiatry. 178, 829\u2013837 (2021).","journal-title":"Am. J. Psychiatry"},{"key":"92313_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/hup.2751","volume":"35","author":"YC Cheng","year":"2020","unstructured":"Cheng, Y. C., Huang, Y. C. & Huang, W. L. Gabapentinoids for treatment of alcohol use disorder: A systematic review and meta-analysis. Hum. Psychopharmacology: Clin. Experimental. 35, 1\u201311 (2020).","journal-title":"Hum. Psychopharmacology: Clin. Experimental"},{"key":"92313_CR29","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1001\/jamainternmed.2020.0249","volume":"180","author":"RF Anton","year":"2020","unstructured":"Anton, R. F. et al. Efficacy of Gabapentin for the treatment of alcohol use disorder in patients with alcohol withdrawal symptoms: A randomized clinical trial. JAMA Intern. Med. 180, 728\u2013736 (2020).","journal-title":"JAMA Intern. Med."},{"key":"92313_CR30","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1002\/hep.31496","volume":"73","author":"JS Bajaj","year":"2021","unstructured":"Bajaj, J. S. et al. A randomized clinical trial of fecal microbiota transplant for alcohol use disorder. Hepatology 73, 1688\u20131700 (2021).","journal-title":"Hepatology"},{"key":"92313_CR31","doi-asserted-by":"crossref","unstructured":"Wolstenholme, J. T. et al. Reduced alcohol preference and intake after fecal transplant in patients with alcohol use disorder is transmissible to germ-free mice. Nature Communications 13, 6198 (2022).","DOI":"10.1038\/s41467-022-34054-6"},{"key":"92313_CR32","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1093\/annonc\/mdx108","volume":"28","author":"N Chaput","year":"2017","unstructured":"Chaput, N. et al. Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab. Ann. Oncol. 28, 1368\u20131379 (2017).","journal-title":"Ann. Oncol."},{"key":"92313_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40168-020-00811-2","volume":"8","author":"Y Heshiki","year":"2020","unstructured":"Heshiki, Y. et al. Predictable modulation of cancer treatment outcomes by the gut microbiota. Microbiome 8, 1\u201314 (2020).","journal-title":"Microbiome"},{"key":"92313_CR34","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1093\/advances\/nmz049","volume":"10","author":"RL Hughes","year":"2019","unstructured":"Hughes, R. L., Kable, M. E., Marco, M. & Keim, N. L. The role of the gut Microbiome in predicting response to diet and the development of precision nutrition models. Part II: results. Adv. Nutr. 10, 979\u2013998 (2019).","journal-title":"Adv. Nutr."},{"key":"92313_CR35","doi-asserted-by":"publisher","first-page":"11703","DOI":"10.3390\/ijms241411703","volume":"24","author":"L Daddi","year":"2023","unstructured":"Daddi, L. et al. Baseline gut Microbiome signatures correlate with immunogenicity of SARS-CoV-2 mRNA vaccines. Int. J. Mol. Sci. 24, 11703 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"92313_CR36","doi-asserted-by":"publisher","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60 (2011).","journal-title":"Genome Biol."},{"key":"92313_CR37","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.biopsych.2023.08.004","volume":"95","author":"RS Hofford","year":"2024","unstructured":"Hofford, R. S. & Kiraly, D. D. Clinical and preclinical evidence for gut Microbiome mechanisms in substance use disorders. Biol. Psychiatry. 95, 329\u2013338 (2024).","journal-title":"Biol. Psychiatry"},{"key":"92313_CR38","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.bbr.2014.07.027","volume":"277","author":"SM O\u2019Mahony","year":"2015","unstructured":"O\u2019Mahony, S. M., Clarke, G., Borre, Y. E., Dinan, T. G. & Cryan, J. F. Serotonin, Tryptophan metabolism and the brain-gut-microbiome axis. Behav. Brain. Res. 277, 32\u201348 (2015).","journal-title":"Behav. Brain. Res."},{"key":"92313_CR39","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41587-020-0548-6","volume":"38","author":"GM Douglas","year":"2020","unstructured":"Douglas, G. M. et al. PICRUSt2 for prediction of metagenome functions. Nat. Biotechnol. 38, 685\u2013688 (2020).","journal-title":"Nat. Biotechnol."},{"key":"92313_CR40","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/s41564-018-0337-x","volume":"4","author":"M Valles-Colomer","year":"2019","unstructured":"Valles-Colomer, M. et al. The neuroactive potential of the human gut microbiota in quality of life and depression. Nat. Microbiol. 4, 623\u2013632 (2019).","journal-title":"Nat. Microbiol."},{"key":"92313_CR41","doi-asserted-by":"publisher","first-page":"103091","DOI":"10.1016\/j.nicl.2022.103091","volume":"35","author":"K Marinkovic","year":"2022","unstructured":"Marinkovic, K., Alderson Myers, A. B., Arienzo, D., Sereno, M. I. & Mason, G. F. Cortical GABA levels are reduced in young adult binge drinkers: association with recent alcohol consumption and sex. Neuroimage Clin. 35, 103091 (2022).","journal-title":"Neuroimage Clin."},{"key":"92313_CR42","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1177\/1073858402238515","volume":"8","author":"OAC Petroff","year":"2002","unstructured":"Petroff, O. A. C. Book review: GABA and glutamate in the human brain. Neuroscientist 8, 562\u2013573 (2002).","journal-title":"Neuroscientist"},{"key":"92313_CR43","doi-asserted-by":"publisher","first-page":"813075","DOI":"10.3389\/fnins.2022.813075","volume":"16","author":"Z Dong","year":"2022","unstructured":"Dong, Z. et al. Gut microbiome: A potential indicator for predicting treatment outcomes in major depressive disorder. Front. Neurosci. 16, 813075 (2022).","journal-title":"Front. Neurosci."},{"key":"92313_CR44","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1002\/art.41622","volume":"73","author":"A Artacho","year":"2021","unstructured":"Artacho, A. et al. The pretreatment gut Microbiome is associated with lack of response to methotrexate in New-Onset rheumatoid arthritis. Arthritis Rheumatol. 73, 931\u2013942 (2021).","journal-title":"Arthritis Rheumatol."},{"key":"92313_CR45","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1080\/00952990.2019.1669629","volume":"46","author":"K Litwinowicz","year":"2020","unstructured":"Litwinowicz, K., Choroszy, M. & Waszczuk, E. Changes in the composition of the human intestinal Microbiome in alcohol use disorder: a systematic review. Am. J. Drug Alcohol Abuse. 46, 4\u201312 (2020).","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"92313_CR46","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.nutres.2020.09.004","volume":"83","author":"S Gurwara","year":"2020","unstructured":"Gurwara, S. et al. Alcohol use alters the colonic mucosa\u2013associated gut microbiota in humans. Nutr. Res. 83, 119\u2013128 (2020).","journal-title":"Nutr. Res."},{"key":"92313_CR47","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1038\/s41575-022-00631-9","volume":"19","author":"PD Cani","year":"2022","unstructured":"Cani, P. D., Depommier, C., Derrien, M., Everard, A. & de Vos, W. M. Akkermansia muciniphila: paradigm for next-generation beneficial microorganisms. Nat. Rev. Gastroenterol. Hepatol. 19, 625\u2013637 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"92313_CR48","doi-asserted-by":"publisher","first-page":"1224155","DOI":"10.3389\/fcimb.2023.1224155","volume":"13","author":"W Lei","year":"2023","unstructured":"Lei, W. et al. Akkermansia muciniphila in neuropsychiatric disorders: friend or foe? Front. Cell. Infect. Microbiol. 13, 1224155 (2023).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"92313_CR49","doi-asserted-by":"crossref","unstructured":"Si, J., Kang, H., You, H. J. & Ko, G. Revisiting the role of Akkermansia muciniphila as a therapeutic bacterium. Gut Microbes 14, (2022).","DOI":"10.1080\/19490976.2022.2078619"},{"key":"92313_CR50","doi-asserted-by":"publisher","first-page":"210784","DOI":"10.3389\/fmicb.2016.01934","volume":"7","author":"R Mazzoli","year":"2016","unstructured":"Mazzoli, R. & Pessione, E. The neuro-endocrinological role of microbial glutamate and GABA signaling. Front. Microbiol. 7, 210784 (2016).","journal-title":"Front. Microbiol."},{"key":"92313_CR51","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/s41564-018-0307-3","volume":"4","author":"P Strandwitz","year":"2018","unstructured":"Strandwitz, P. et al. GABA-modulating bacteria of the human gut microbiota. Nat. Microbiol. 4, 396\u2013403 (2018).","journal-title":"Nat. Microbiol."},{"key":"92313_CR52","doi-asserted-by":"publisher","first-page":"8852","DOI":"10.1080\/10408398.2023.2204373","volume":"64","author":"D Hou","year":"2023","unstructured":"Hou, D. et al. Gamma-aminobutyric acid (GABA): a comprehensive review of dietary sources, enrichment technologies, processing effects, health benefits, and its applications. Crit. Rev. Food Sci. Nutr.\u00a064, 8852\u20138874 (2023).","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"92313_CR53","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.3390\/nu15071571","volume":"15","author":"M Butts","year":"2023","unstructured":"Butts, M., Sundaram, V. L., Murughiyan, U., Borthakur, A. & Singh, S. The influence of alcohol consumption on intestinal nutrient absorption: A comprehensive review. Nutrients 15, 1571 (2023).","journal-title":"Nutrients"},{"key":"92313_CR54","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1093\/alcalc\/agz030","volume":"54","author":"T Voutilainen","year":"2019","unstructured":"Voutilainen, T. & K\u00e4rkk\u00e4inen, O. Changes in the human metabolome associated with alcohol use: A review. Alcohol Alcohol. 54, 225\u2013234 (2019).","journal-title":"Alcohol Alcohol."},{"key":"92313_CR55","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1046\/j.1471-4159.1998.70010299.x","volume":"70","author":"S Okuda","year":"1998","unstructured":"Okuda, S., Nishiyama, N., Saito, H. & Katsuki, H. 3-Hydroxykynurenine, an endogenous oxidative stress generator, causes neuronal cell death with apoptotic features and region selectivity. J. Neurochem. 70, 299\u2013307 (1998).","journal-title":"J. Neurochem"},{"key":"92313_CR56","doi-asserted-by":"crossref","unstructured":"Vich Vila, A. et al. Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nature Communications 11, 362 (2020).","DOI":"10.1038\/s41467-019-14177-z"},{"key":"92313_CR57","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.seizure.2004.04.016","volume":"13","author":"IE Leppik","year":"2004","unstructured":"Leppik, I. E. Zonisamide: chemistry, mechanism of action, and pharmacokinetics. Seizure 13, S5\u2013S9 (2004).","journal-title":"Seizure"},{"key":"92313_CR58","doi-asserted-by":"crossref","unstructured":"Pettinati, H. M. et al. A structured approach to medical management: a psychosocial intervention to support pharmacotherapy in the treatment of alcohol dependence. J. Stud. Alcohol. Drugs. Suppl. 66, 170\u2013178 (2005).","DOI":"10.15288\/jsas.2005.s15.170"},{"key":"92313_CR59","doi-asserted-by":"crossref","unstructured":"Sobell, L. C. & Sobell, M. B. Timeline Follow-Back. Measuring Alcohol Consumption 41\u201372 (1992).","DOI":"10.1007\/978-1-4612-0357-5_3"},{"key":"92313_CR60","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","volume":"37","author":"E Bolyen","year":"2019","unstructured":"Bolyen, E. et al. Reproducible, interactive, scalable and extensible Microbiome data science using QIIME 2. Nat. Biotechnol. 37, 852\u2013857 (2019).","journal-title":"Nat. Biotechnol."},{"key":"92313_CR61","doi-asserted-by":"crossref","unstructured":"Callahan, B. J. et al. DADA2: High-resolution sample inference from illumina amplicon data. Nat. Methods. 13, 581\u2013583 (2016).","DOI":"10.1038\/nmeth.3869"},{"key":"92313_CR62","unstructured":"Bisanz, J. E. & qiime 2R: Importing QIIME2 artifacts and associated data into R sessions. Preprint at (2018). https:\/\/github.com\/jbisanz\/qiime2R"},{"key":"92313_CR63","doi-asserted-by":"publisher","first-page":"e61217","DOI":"10.1371\/journal.pone.0061217","volume":"8","author":"PJ McMurdie","year":"2013","unstructured":"McMurdie, P. J. & Holmes, S. Phyloseq: an R package for reproducible interactive analysis and graphics of Microbiome census data. PLoS One. 8, e61217 (2013).","journal-title":"PLoS One"},{"key":"92313_CR64","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.21105\/joss.03201","volume":"6","author":"DJ Barnett","year":"2021","unstructured":"Barnett, D. J., Arts, I. C. & Penders, J. MicroViz: an R package for Microbiome data visualization and statistics. J. Open. Source Softw. 6, 3201 (2021).","journal-title":"J. Open. Source Softw."},{"key":"92313_CR65","unstructured":"Jari et al. vegan: Community Ecology Package. Preprint at https:\/\/CRAN.R-project.org\/package=vegan (2022)."},{"key":"92313_CR66","doi-asserted-by":"crossref","unstructured":"Wickham, H. Ggplot2 (Springer International Publishing, 2016).","DOI":"10.1007\/978-3-319-24277-4"},{"key":"92313_CR67","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.21105\/joss.01686","volume":"4","author":"H Wickham","year":"2019","unstructured":"Wickham, H. et al. Welcome to the tidyverse. J. Open. Source Softw. 4, 1686 (2019).","journal-title":"J. Open. Source Softw."},{"key":"92313_CR68","doi-asserted-by":"publisher","first-page":"117155","DOI":"10.1016\/j.trac.2023.117155","volume":"166","author":"Y Jin","year":"2023","unstructured":"Jin, Y., Chi, J., LoMonaco, K., Boon, A. & Gu, H. Recent review on selected xenobiotics and their impacts on gut Microbiome and metabolome. TRAC Trends Anal. Chem. 166, 117155 (2023).","journal-title":"TRAC Trends Anal. Chem."},{"key":"92313_CR69","doi-asserted-by":"publisher","first-page":"3124","DOI":"10.1021\/acs.jproteome.1c00019","volume":"20","author":"Y Wei","year":"2021","unstructured":"Wei, Y. et al. Early breast Cancer detection using untargeted and targeted metabolomics. J. Proteome Res. 20, 3124\u20133133 (2021).","journal-title":"J. Proteome Res."},{"key":"92313_CR70","doi-asserted-by":"publisher","first-page":"12355","DOI":"10.1021\/acs.analchem.5b03812","volume":"87","author":"H Gu","year":"2015","unstructured":"Gu, H., Zhang, P., Zhu, J. & Raftery, D. Globally optimized targeted mass spectrometry: reliable metabolomics analysis with broad coverage. Anal. Chem. 87, 12355\u201312362 (2015).","journal-title":"Anal. Chem."},{"key":"92313_CR71","doi-asserted-by":"publisher","first-page":"7367","DOI":"10.1007\/s00216-014-8169-x","volume":"406","author":"W Yao","year":"2014","unstructured":"Yao, W. et al. Integrated plasma and urine metabolomics coupled with HPLC\/QTOF-MS and chemometric analysis on potential biomarkers in liver injury and hepatoprotective effects of Er-Zhi-Wan. Anal. Bioanal Chem. 406, 7367\u20137378 (2014).","journal-title":"Anal. Bioanal Chem."},{"key":"92313_CR72","first-page":"13","volume":"1","author":"MJ Conroy","year":"2013","unstructured":"Conroy, M. J. et al. LIPID MAPS: update to databases and tools for the lipidomics community. Nucleic Acids Res. 1, 13\u201314 (2013).","journal-title":"Nucleic Acids Res."},{"key":"92313_CR73","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1038\/s41592-020-0942-5","volume":"17","author":"J Xue","year":"2020","unstructured":"Xue, J., Guijas, C., Benton, H. P., Warth, B. & Siuzdak, G. METLIN MS2 molecular standards database: a broad chemical and biological resource. Nat. Methods. 17, 953\u2013954 (2020).","journal-title":"Nat. Methods"},{"key":"92313_CR74","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1021\/ed100697w","volume":"87","author":"HE Pence","year":"2010","unstructured":"Pence, H. E. & Williams, A. ChemSpider: an online chemical information resource. J. Chem. Educ. 87, 1123\u20131124 (2010).","journal-title":"J. Chem. Educ."},{"key":"92313_CR75","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1021\/es5002105","volume":"48","author":"EL Schymanski","year":"2014","unstructured":"Schymanski, E. L. et al. Identifying small molecules via high resolution mass spectrometry: communicating confidence. Environ. Sci. Technol. 48, 2097\u20132098 (2014).","journal-title":"Environ. Sci. Technol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92313-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92313-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92313-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T09:16:10Z","timestamp":1743326170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92313-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,26]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["92313"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-92313-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,26]]},"assertion":[{"value":"22 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"AJA is a consultant to Sobrera Pharmaceuticals. All other authors report no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest disclosure"}},{"value":"Participants were recruited from the community at three sites (two in Connecticut and one in Virginia) as part of a double-blind, randomized, placebo-controlled study investigating the use of zonisamide in reducing drinking (ClinicalTrials.gov identifier: NCT02900352, Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of Action (Z-Comp), first registered 14\/09\/2016","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial registration"}}],"article-number":"10486"}}